4
Changes in Ownership
NewAmsterdam Pharma Co N.V. Filed Acc 0000950170-25-010575
Chief Operating Officer sold 129,559 shares
- Chief Operating Officer acquired 129,559 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Kling Douglas F · Chief Operating Officer
Table I: Non-derivative
6 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2025-01-27 | Exercise or conversion : show line 1 in the form 10b5-1 | +104,174 | 148,174 | D |
| 2025-01-27 | Sale : show line 2 in the form 10b5-1 | −80,359 | 67,815 | D |
| 2025-01-27 | Sale : show line 3 in the form 10b5-1 | −23,815 | 44,000 | D |
| 2025-01-28 | Exercise or conversion : show line 4 in the form 10b5-1 | +25,385 | 69,385 | D |
| 2025-01-28 | Sale : show line 5 in the form 10b5-1 | −20,237 | 49,148 | D |
| 2025-01-28 | Sale : show line 6 in the form 10b5-1 | −5,148 | 44,000 | D |
| Open-market sales · 129,559 sh | ||||
Table II: Derivative
2 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2025-01-27 | Exercise or conversion : show line 7 in the form 10b5-1 Option (right to buy) | −104,174 | 321,971 | D |
| 2025-01-28 | Exercise or conversion : show line 8 in the form 10b5-1 Option (right to buy) | −25,385 | 296,586 | D |
Loading xslF345X05/ownership.xml…